Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology
about
Alprazolam for essential tremorAlprazolam for essential tremorZonisamide for essential tremorTopiramate for essential tremorPregabalin for essential tremorThe treatment of tremorThe emerging role of transcranial magnetic resonance imaging-guided focused ultrasound in functional neurosurgery.Focused Ultrasound for Essential Tremor: Review of the Evidence and Discussion of Current Hurdles.MR-guided focused ultrasound: a new generation treatment of Parkinson's disease, essential tremor and neuropathic pain.Therapeutic advances in tremor.Reliability of a new scale for essential tremor.Alcohol challenge and sensitivity to change of the Essential Tremor Rating Assessment Scale.Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association.The potential of LINGO-1 as a therapeutic target for essential tremor.Lithium tremor revisited: pathophysiology and treatment.Effects of alprazolam on cortical activity and tremors in patients with essential tremorTwo children with tremor.Effect of Crocus sativus extracts and its active constituent safranal on the harmaline-induced tremor in mice.High-Dose Benzodiazepine Dependence: A Qualitative Study of Patients' Perceptions on Initiation, Reasons for Use, and Obtainment.Impact of an Interdisciplinary Deep Brain Stimulation Screening Model on Post-Surgical Complications in Essential Tremor Patients.Octanoic acid suppresses harmaline-induced tremor in mouse model of essential tremorDistinguishing essential tremor from Parkinson's disease: bedside tests and laboratory evaluations.Essential tremor is not a neurodegenerative diseaseEffect of Primidone on Dentate Nucleus γ-Aminobutyric Acid Concentration in Patients With Essential Tremor.The balance and gait disorder of essential tremor: what does this mean for patients?Ethosuximide for Essential Tremor: An Open-Label Trial.Efficacy and Safety of Topiramate for Essential Tremor: A Meta-Analysis of Randomized Controlled TrialsWorse and Worse and Worse: Essential Tremor Patients' Longitudinal Perspectives on Their Condition.Immediate and Longitudinal Alterations of Functional Networks after Thalamotomy in Essential Tremor.Pharmacotherapy of essential tremorApproach to a tremor patient.Medical treatment of essential tremor.New horizons in the pathogenesis, assessment and management of movement disorders.Methodological issues in clinical drug development for essential tremor.Paroxysmal sympathetic hyperactivity after acute brain injury.The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseasesThe GABA Hypothesis in Essential Tremor: Lights and Shadows.Zonisamide for essential tremor.Deep Brain Stimulation Target Selection for Parkinson's Disease.Topiramate for essential tremor.
P2860
Q24187196-F98A2FE1-EFC8-43CB-AF6A-ACCBD14DD58BQ24201430-E84FED31-AE15-4B98-9486-39E9006B7656Q24201497-F404D57D-9BEB-4452-8040-9C0597A5A5E9Q24201606-F0512198-7CE2-48D1-98EF-F72C47027333Q24203614-42695B6B-37DF-42A7-9AF9-46DE55E4D95DQ27022935-E3FD0145-C4EF-43B2-90BE-3CFA256F9275Q30277005-74646F54-FBAD-4B84-A886-A0A5DC248CF4Q30356841-14183736-3256-40B9-8F1D-380E3E3075C7Q30393753-15515993-9593-4390-9344-C54E1E09F6CCQ30988475-DB015D96-9DAF-49E8-A091-8FCDC2A03880Q34150326-81E13ABB-0FA0-4E59-85BC-4A67A5DDBC48Q34303864-99A80F6B-3599-4828-A03D-9A9AF65ADDA8Q34376919-BD86D520-794C-4A01-9BCD-02473D2B1BFDQ34471202-72D20FA7-E182-404D-89D6-4E0C13E90877Q34802606-9B94F59C-E5E1-4751-BE35-7F94C8C875C2Q35131330-B1571544-EB4C-4455-8635-A684D9441F0EQ35463162-53145293-EFCB-4010-AC56-8B0AFE3E4498Q35763443-0076555E-1E25-40CE-A6EA-3B0F3CFFC6AEQ35837717-32405AF6-64E8-4B26-BB83-7CFEC086AA36Q35879615-E6288230-F190-4CA4-92BE-2FBF50218E29Q36233147-D8866BD2-D5DC-4B36-A80A-63F50FDB917FQ36331828-5D3C1DD9-D634-4F9F-8FBB-27D3545ABAAEQ36340954-CC20E212-68C0-459F-BE48-C0418A8649C5Q36611004-01CF21F1-A8CB-43BA-A52C-FDC2F0943652Q36999731-55F45CC4-58CF-4C97-AFA9-342E898CD746Q37099546-03375DD6-A66E-44D3-9BDB-F590058E05D2Q37176201-8BCF9C9A-526D-4CEC-895E-59C93666EC93Q37335308-06A74F87-0208-49BA-B477-8F57BCACA0E1Q37361003-3C00A3C5-09AD-4259-9128-73EC91ED217FQ37414979-764D3888-7901-4E56-B068-9B766317621AQ37484363-986C1042-7113-48BC-BF89-4EA1EADEFC4AQ37723544-4FA53FFA-71A9-4A44-B6EF-384553373C52Q38036239-7467AD36-7A04-4331-8665-A275284126C0Q38084595-5D047166-0271-4D55-ACB5-7E0C6B25937FQ38115499-E6FB193A-0329-4686-857B-C6D54116B31DQ38157892-FE12D3D2-A6FD-49E1-83C1-684F2D7009E2Q38239686-A9EEF059-4DE5-480F-BE5C-FF16F610D308Q38610647-FBF13064-5B35-44CE-9B57-D1A10F82194CQ38774553-5F8BE530-5C03-4BAA-89D6-5C781FBCD756Q38836991-C13F3F66-5E5E-4606-8AC4-E3B7B59160E3
P2860
Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Evidence-based guideline updat ...... American Academy of Neurology
@ast
Evidence-based guideline updat ...... American Academy of Neurology
@en
Evidence-based guideline updat ...... American Academy of Neurology
@nl
type
label
Evidence-based guideline updat ...... American Academy of Neurology
@ast
Evidence-based guideline updat ...... American Academy of Neurology
@en
Evidence-based guideline updat ...... American Academy of Neurology
@nl
prefLabel
Evidence-based guideline updat ...... American Academy of Neurology
@ast
Evidence-based guideline updat ...... American Academy of Neurology
@en
Evidence-based guideline updat ...... American Academy of Neurology
@nl
P2093
P2860
P3181
P1433
P1476
Evidence-based guideline updat ...... American Academy of Neurology
@en
P2093
G S Gronseth
K L Sullivan
T A Zesiewicz
W J Weiner
P2860
P304
P3181
P356
10.1212/WNL.0B013E318236F0FD
P407
P577
2011-10-19T00:00:00Z